Neuropathic Pain Treatments and Quality of Life Results in Leprosy Patients (P6.313)

CONCLUSION: This study highlights the superiority of Group 1 compared to Group 2 when analyzing the results. Although Group 1 was statistically superior to Group 2, the Limitations by Emotional Aspects criteria showed no statistical difference in both. One might speculate as hypothesis for this finding, aspects that go beyond pharmacotherapy, such as the impact of stigma related to the presence of cutaneous manifestations.Disclosure: Dr. Dornas has nothing to disclose. Dr. Nascimento has nothing to disclose. Dr. Pupe has nothing to disclose. Dr. Araujo has nothing to disclose. Dr. Davidovich has nothing to disclose. Dr. Vianna has nothing to disclose. Dr. Coutinho has nothing to disclose. Dr. Bittar has nothing to disclose.
Source: Neurology - Category: Neurology Authors: Tags: Lyme and Other CNS Infections Source Type: research